What is Baclofen Used For?
Baclofen is primarily used as a muscle relaxant to treat spasticity—particularly from multiple sclerosis, spinal cord injuries, and other spinal cord diseases—and has emerging evidence for maintaining alcohol abstinence in patients with alcohol use disorder and liver disease. 1
FDA-Approved Indications
According to the FDA label, baclofen is indicated for:
- Alleviation of spasticity from multiple sclerosis, particularly for relief of flexor spasms, concomitant pain, clonus, and muscular rigidity
- Spinal cord injuries and other spinal cord diseases
- Patients must have reversible spasticity where treatment will aid in restoring residual function 1
Baclofen is NOT indicated for:
- Skeletal muscle spasm from rheumatic disorders
- Stroke, cerebral palsy, or Parkinson's disease (efficacy not established) 1
Clinical Practice Applications
Spasticity Management (Primary Use)
Oral baclofen should be considered for spasticity resulting in pain, poor skin hygiene, or decreased function 2. The treatment follows a stepwise approach:
- First-line: Positioning, range of motion exercises, stretching, splinting, serial casting
- Pharmacological: Oral baclofen (along with tizanidine or dantrolene) when conservative measures fail
- Advanced: Intrathecal baclofen for chronic patients unresponsive to oral therapy 2, 3
Key clinical point: Oral baclofen may cause significant sedation and has less impact on spasticity in stroke victims compared to other conditions 2. Diazepam should be avoided during stroke recovery due to deleterious effects 2.
Intrathecal Baclofen Therapy
Intrathecal baclofen should be considered for chronic stroke patients (>6 months post-stroke) with spasticity causing pain, poor skin hygiene, or decreased function when oral medications fail 2, 3. This route delivers baclofen directly to cerebrospinal fluid, bypassing the blood-brain barrier and achieving therapeutic effects at 1/100th the oral dose 4.
Critical safety warning: Abrupt withdrawal of intrathecal baclofen is potentially life-threatening, causing high fever, altered mental status, rebound spasticity, muscle rigidity, rhabdomyolysis, multiorgan failure, and death 5. Perioperative management requires specialist input 5.
Alcohol Use Disorder (Emerging Indication)
Baclofen is the only pharmacotherapy for alcohol use disorder tested in patients with alcoholic liver disease and cirrhosis 6, 7. A 12-week course of baclofen (10 mg three times daily) effectively maintained abstinence by reducing alcohol craving in cirrhotic patients 6.
Evidence quality: One randomized trial in cirrhotic patients showed benefit 8, though a subsequent trial in hepatitis C patients showed no superiority over placebo 7. The French regulatory agency issued a temporary recommendation for baclofen use (not exceeding 80 mg/day) for alcohol use disorder 7.
Important limitation: Patients with hepatic encephalopathy were excluded from trials, as baclofen may impair mentation—a side effect potentially exacerbated in advanced liver disease 8.
Recent systematic review evidence (2023) shows baclofen likely reduces relapse risk (RR 0.87) and increases percentage of days abstinent (MD 9.07 days), mainly among detoxified participants 9.
Dosing Considerations
- Oral therapy: Typically 30-300 mg daily, with most studies using ≤30 mg (low dose) or 30-100 mg (medium dose) 9
- Intrathecal therapy: Initial doses around 80-100 µg at discharge, escalating to 200-400 µg after 1 year, with cerebral spasticity requiring highest doses (578 µg at 10 years) 10
- Alcohol use disorder: 30-60 mg/day divided doses 8
Critical Safety Considerations
Withdrawal symptoms from abrupt discontinuation include: visual and auditory hallucinations, anxiety, agitation, delirium, fever, tremors, tachycardia, and seizures 5. Baclofen must be continued preoperatively, including the day of operation 5.
Common adverse effects (25-75% of patients): muscle weakness, nausea, somnolence, paraesthesia, fatigue, dizziness, dry mouth, and muscle spasms/rigidity 9, 11. These effects are dose-related and may limit usefulness of oral therapy 11.
Contraindications: Patients requiring spasticity for upright posture and balance should use baclofen cautiously 1. Monitor patients with epilepsy regularly, as seizure control deterioration has been reported 1.